A network meta-analysis of randomized trials and observational studies on left ventricular assist devices in adult patients with end-stage heart failure
Author(s) -
Elena Cavarretta,
Antonino Marullo,
Sebastiano Sciarretta,
Umberto Benedetto,
Ernesto Greco,
Leonardo Roever,
Euclide Tonelli,
Mariangela Peruzzi,
Alessandra Iaccarino,
Giuseppe BiondiZoccai,
Giacomo Frati
Publication year - 2018
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezy285
Subject(s) - medicine , heart failure , randomized controlled trial , meta analysis , observational study , ventricular assist device , destination therapy , cardiology , stroke (engine) , relative risk , confidence interval , ejection fraction , mechanical engineering , engineering
The use of left ventricular assist devices (LVADs) is an approved treatment option for end-stage heart failure. Several devices have been developed over the years, including 2 newer ones (HeartMate 3 and HeartWare), but an overall comparative analysis has never been performed. We conducted a network meta-analysis of randomized trials on LVAD for adults with end-stage heart failure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom